Jing Yang, Ya Zheng, Xi Gou, K. Pu, Zhaofeng Chen, Qinghong Guo, R. Ji, Haojia Wang, Yuping Wang, Yongning Zhou
tlooto Summary
The prevalence of comorbidities in infected patients and risk factors for severe compared with non-severe patients are assessed to help the health sector guide vulnerable populations and assess the risk of deterioration.
Abstract
Highlights • COVID -19 cases are now confirmed in multiple countries.• Assessed the prevalence of comorbidities in infected patients.• Comorbidities are risk factors for severe compared with non-severe patients.• Help the health sector guide vulnerable populations and assess the risk of deterioration.
Citation format
YANG, Jing, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 94: 91–95.